Search

Your search keyword '"Licordari, Roberto"' showing total 166 results

Search Constraints

Start Over You searched for: Author "Licordari, Roberto" Remove constraint Author: "Licordari, Roberto"
166 results on '"Licordari, Roberto"'

Search Results

2. Pericardial Diseases

3. Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis

6. Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations

7. Transient Left Ventricular Dysfunction from Cardiomyopathies to Myocardial Viability: When and Why Cardiac Function Recovers

8. Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value

9. The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome

10. Systemic Vascular Resistance and Myocardial Work Analysis in Hypertrophic Cardiomyopathy and Transthyretin Cardiac Amyloidosis with Preserved Left Ventricular Ejection Fraction

13. Late Gadolinium Enhancement Dispersion for Predicting Malignant Arrhythmic Events in Patient with Non-Ischemic Dilated Cardiomyopathy

14. Safety and Feasibility of Adenosine Stress CMR in Heart Transplant Recipients with Suspected Cardiac Allograft Vasculopathy

17. Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update.

18. Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study.

19. Arrhythmic risk profile in mitral valve prolapse: A systematic review and metanalysis of 1715 patients.

21. The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population

22. Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study

23. The Role of Advanced Cardiovascular Imaging Modalities in Cardio-Oncology: From Early Detection to Unravelling Mechanisms of Cardiotoxicity

28. Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management

29. Atrial Fibrillation and QT corrected. What is the best formula to use?

30. Off-Target Effects of P2Y12 Receptor Inhibitors: Focus on Early Myocardial Fibrosis Modulation.

32. 381 PROGNOSTIC VALUE OF TWO DIMENSIONAL STRAIN IN EARLY ISCHEMIC HEART DISEASE: A 5-YEAR FOLLOW-UP STUDY

34. 772 SCREENING FOR ANDERSON-FABRY DISEASE IN RELATIVELY YOUNG PATIENTS WITH UNEXPLAINED CONDUCTION DISORDERS REQUIRING PACEMAKER IMPLANTATION

35. 1041 ELECTROCARDIOGRAPHIC HETEROGENEITY OF PATIENTS WITH VARIANT TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: GENOTYPE PHENOTYPE CORRELATIONS

36. 292 QTC CORRECTION IN ATRIAL FIBRILLATION

37. 62 MYOCARDIAL WORK IN CARDIAC AMYLOIDOSIS AND HYPERTENSIVE HEART DISEASE: A PRELIMINARY REPORT

38. 1009 INTRAMYOCARDIAL HEMORRHAGE: A DIFFERENTIAL DIAGNOSIS OF HYPERTROPHY

39. Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality

40. The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic

41. Prognostic value of two‐dimensional strain in early ischemic heart disease: A 5‐year follow‐up study

42. Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis

43. Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease

44. Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality.

47. Mid-basal left ventricular longitudinal dysfunction as a prognostic marker in mutated transthyretin-related cardiac amyloidosis

50. 692 Impact of COVID-19 pandemic on in-hospital outcomes for patients with acute coronary syndrome: a propensity-weighted, multicentre study

Catalog

Books, media, physical & digital resources